Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-04-15

MORPHOLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF CELLS FROM TYPICAL FOCAL CNS LESIONS IN THE RAT FOLLOWING PRENATAL X-IRRADIATION AND THEIR RELATIONSHIPS TO ETHYLNITROSOUREA

Obiettivo

EVALUATION OF NON-STOCHASTIC RISKS TO THE DEVELOPING ORGANISM. DAMAGE TO THE BRAIN AFTER PRENATAL IRRADIATION.
In the present experiments the deoxyribonucleic acid (DNA) repair capability of the foetal brain and liver has been analysed simultaneously with long term observations of rats which were treated in utero either by X-irradiation, ethylnitroso urea (ENU) or both in combination. This should reveal any relationship between the influence on O6-alkylguanine-DNA alkyltransferase activity, which is the specific acceptor protein in the DNA repair process, and the incidence of tumours in the offspring.
X-IRRADIATION (180 KV, 0.2 MM CU, 0.01 GY/MIN; DOSES: 0.25 GY, 0.50 GY, 1.00 GY, AND 1.50 GY) WILL BE APPLIED TO PREGNANT RATS IN THE MORNING OF DAY 14 OF GESTATION. ETHYLNITROSOUREA (ENU) (30 MG/KG BODY WEIGHT) ALONE OR SUBSEQUENT TO X-IRRADIATION WILL BE APPLIED AT THE END OF DAY 14 (INTERVAL 8-12 HOURS). THIS DEVELOPMENTAL STAGE HAS BEEN CHOSEN BECAUSE BOTH ENU AND X-IRRADIATION STILL EXERT A MARKED TERATOGENIC POTENCY WHEREAS THE NEUROONCOGENIC POTENCY OF ENU IS ALREADY INCREASING.THE OFFSPRING FROM THE TREATED ANIMALS, AS WELL AS FROM THE UNTREATED CONTROLS WILL BE REARED BEYOND WEANING.INVESTIGATIONS WILL BE PERFORMED AT THE FOLLOWING TIMES:A.-ON DAY 19 OF PREGNANCY, TO CHARACTERIZE THE HISTOGENETIC EFFECTS AT THE FOREBRAIN IMMEDIATELY BEFORE BIRTH.B.-AT 3-4 MONTHS, IN ORDER TO COMPARE THE OCCURENCE OF RESIDUES OF THE PRENATALLY INDUCED ROSETTES WITH THE ORIGIN, TYPE AND LOCATION OF NOW ARISING EARLY NEOPLASTIC LESIONS.C.-AT 12-16 MONTHS, RESIDUAL DYSPLASTIC LESIONS ARE CORRELATED WITH OVERT GLIOMA FORMATION. ONLY THE LATTER TYPE OF TUMOR CAN YIELD RELIABLE DATA BECAUSE IT REPRESENTS ABOUT 85% OF ENU-INDUCED BRAIN TUMORS.MEMBRANE PROPERTIES OF HETEROTOPIC CELLS REPRESENT AN ALTERNATIVE PATHWAY IN RADIATION TERATOLOGY, COMPLEMENTARY TO DNA-RELATED RESEARCH.IT IS SURMISED THAT THE CORRELATIONS EXIST BETWEEN THE OUTSTANDING ADHESIVE PROPERTIES OF THE HETEROTOPICALLY DISPLACED CELLS AND THEIR NEGATIVE INFLUENCE UPON CARCINOGENESIS. THIS IMPLIES STUDIES OF EMBRYONIC AND TUMOR SPECIFIC ANTIGENS AND THEIR POSSIBLE CROSS-REACTIVITIES. CHARACTERIZATION OF THE SURFACE PROPERTIES OF CNS CELLS CONTRIBUTING TO THE NORMAL MICROSCOPIC ANATOMY AS WELL AS OF CELLS LOCATED WITHIN LESIONS. CHARACTERIZATION OF THE LECTIN BINDING PROPERTIES, USING PNA, WGA, SBA, RCA WHICH ARE SPECIFIC FOR DEVELOPING NEUROECTODERMAL TISSUES, BUT ALSO FOR CERTAIN BRAIN TUMORS.CHARACTERIZATION OF CELL ADHESION-RELATED ANTIGENS BY MEANS OF SPECIFIC ANTIBODIES. TOPOGRAPHICAL DISTRIBUTION PATTERN OF PEROXIDASE-LABELLED OR OF FITC-LABELLED ANTIBODIES IN NORMAL AND IN PATHOLOGICALLY ALTERED BRAIN TISSUE. CORRELATION BETWEEN THE ANTIBODY AFFINITY PATTERN AND THE DEGREE OF MALFORMATION OR THE TYPE AND ORIGIN OF GLIOMAS.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Dati non disponibili

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CSC - Cost-sharing contracts

Coordinatore

GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT GMBH
Contributo UE
Nessun dato
Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato
Il mio fascicolo 0 0